Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSant Uk.8fepf Regulatory News (SANB)

Share Price Information for Sant Uk.8fepf (SANB)

Share Price is delayed by 15 minutes
Get Live Data
142.00    0.00 (0.00%)
Bid:
139.00
Ask:
144.00
Spread: 5.00 (3.597%)
Market Cap: -
SANB Live PriceLast checked at - London Stock Exchange

Intraday Sant Uk.8fepf Share Chart

Santander UK Board changes

3 Oct 2025 07:00

RNS Number : 8890B
Santander UK Group Holdings PLC
03 October 2025
 

3 October 2025

Santander UK Group Holdings plc and Santander UK plc (together "Santander UK")

BOARD CHANGES

Santander UK today announces that Mahesh Aditya has been appointed as a Banco Santander, S.A. nominated Non-Executive Director of the Santander UK Boards, effective from 1 October 2025. He replaces Dirk Marzluf who stepped down from the Boards of Santander UK with effect from 30 September 2025.

Santander UK Chairman, Tom Scholar said: "I am delighted to welcome Mahesh to the Boards of Santander UK. Mahesh will bring a breadth of experience to the Board, including in depth knowledge of risk management in banking during a period of strategically important transformation for Santander UK. Dirk has been a highly valued member of the Board during his six year tenure and I would like to thank him for his contribution to Santander UK in that time."

- Ends -

For media enquiries, please contact:

Stewart Todd Head of Communications mediarelations@santander.co.uk

Notes to Editors:

Mahesh Aditya

Mahesh has been Santander's Group Chief Risk Officer since 2023. 

Mahesh joined Santander in 2017 as Chief Operating Officer of Santander Holdings USA, Inc (SHUSA) and took the position of US Chief Risk Officer in 2018 until 2019 when he became Santander Consumer USA CEO, holding that position until 2023. 

Mahesh has over 30 years' experience in financial services with particular focus on international markets Risk Management. He specialises in building organisations, establishing control processes, project management and managing through a variety of regulatory environments.

Mahesh is a director of the SHUSA, PagoNxt, S.L., Open Bank, S.A. and Santander Consumer Finance, S.A. Boards.

Additional information about Santander UK and Banco Santander

 

Santander UK is a financial services provider in the UK that offers a wide range of personal and commercial financial products and services. The bank serves its customers via a nationwide branch network, telephone, mobile and online banking. Santander UK is subject to the full supervision of the FCA and the PRA in the UK. Santander UK plc customers' eligible deposits are protected by the FSCS in the UK.

Banco Santander (SAN SM, STD US, BNC.LN) is a leading commercial bank, founded in 1857 and headquartered in Spain and one of the largest banks in the world by market capitalisation. The group's activities are consolidated into five global businesses: Retail & Commercial Banking, Digital Consumer Bank, Corporate & Investment Banking (CIB), Wealth Management & Insurance and Payments (PagoNxt and Cards). This operating model allows the bank to better leverage its unique combination of global scale and local leadership. Banco Santander aims to be the best open financial services platform providing services to individuals, SMEs, corporates, financial institutions and governments. The bank's purpose is to help people and businesses prosper in a simple, personal and fair way.

Banco Santander has a listing of its ordinary shares on the London Stock Exchange and Santander UK plc has preference shares listed on the London Stock Exchange.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABUBDGLSGDGUD
12
Date   Source Headline
5th Jun 20261:20 pmRNSPublication of a Supplementary Prospectus
5th Jun 20261:15 pmRNSPublication of a Supplementary Prospectus
29th May 20263:49 pmRNSAdmission to trading of Transferable Securities
18th May 20264:01 pmRNSNotice of Redemption
18th May 20263:23 pmRNSAdmission to trading of Transferable Securities
15th May 20262:49 pmRNSPublication of Final Terms
8th May 202610:58 amRNSPublication of a Supplementary Prospectus
1st May 20264:42 pmRNSPublication of a Supplementary Prospectus
1st May 20264:38 pmRNSPublication of a Supplementary Prospectus
1st May 20267:00 amRNSCash Acquisition of TSB Banking Group plc
29th Apr 20267:15 amRNSQuarterly Management Statement - Q1 2026
28th Apr 20264:01 pmRNSAdmission to Trading of Transferable Securities
1st Apr 20263:56 pmRNSPublication of a Prospectus
26th Mar 202611:12 amRNSAdmission to trading of Transferable Securities
25th Mar 20264:30 pmRNSPublication of Final Terms
17th Mar 202612:57 pmRNSPublication of a Prospectus
16th Mar 20264:43 pmRNSNotice of Redemption
10th Mar 20262:08 pmRNSPublication of a Supplementary Prospectus
10th Mar 20262:08 pmRNSPublication of a Supplementary Prospectus
10th Mar 20261:59 pmRNSPublication of a Supplementary Prospectus
10th Mar 20261:59 pmRNSPublication of a Supplementary Prospectus
10th Mar 20267:53 amRNSAnnual Financial Report
10th Mar 20267:53 amRNSAnnual Financial Report
26th Feb 202610:45 amRNSFinal Terms
17th Feb 202612:36 pmRNSPublication of Final Terms
4th Feb 20261:47 pmRNSPublication of a Supplementary Prospectus
4th Feb 20261:42 pmRNSPublication of a Supplementary Prospectus
4th Feb 20267:15 amRNSQuarterly Management Statement – Q4 2025
30th Jan 202610:31 amRNSSantander UK - Chief Executive Officer appointment
13th Jan 20264:29 pmRNSNotice of Redemption
29th Oct 20257:00 amRNSUpdate on Q3 2025 Results
3rd Oct 202511:00 amRNSSantander UK CEO to step down
3rd Oct 20257:00 amRNSSantander UK Board changes
29th Aug 20251:42 pmRNSPublication of Supplementary Prospectus
29th Aug 20251:33 pmRNSPublication of Supplementary Prospectus
29th Aug 20257:30 amRNSHalf-year Report 30 June 2025
30th Jul 20252:10 pmRNSPublication of Suppl.Prospcts
30th Jul 20252:04 pmRNSPublication of Suppl.Prospcts
30th Jul 20257:15 amRNSQuarterly Management Statement Q2 2025
21st May 20252:11 pmRNSPublication of Final Terms
16th May 20254:15 pmRNSChair Appointment
30th Apr 202512:43 pmRNSPublication of Supplementary Prospectus
30th Apr 202512:32 pmRNSPublication of Supplementary Prospectus
30th Apr 20257:15 amRNSQuarterly Management Statement – Q1 2025
4th Apr 20253:04 pmRNSPublication of a Prospectus
2nd Apr 20254:22 pmRNSNotice of Redemption
25th Mar 20259:40 amRNSPublication of Final Terms
25th Mar 20259:36 amRNSPublication of Final Terms
24th Mar 202512:55 pmRNSPublication of Final Terms
21st Mar 20255:16 pmRNSPublication of a Prospectus
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.